Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

574
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
574

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dual-pilot phase recovery with pair-wise maximum-ratio combining for coherent PONs.

Optics letters·2026
Same author

Simplified layered MLSE for PAM4 short-reach optical interconnects.

Optics express·2026
Same author

Physics-informed neural Volterra compensation enabling over 2600× efficiency improvement in 12,057-km ultra-long-haul coherent transmission.

Communications engineering·2026
Same author

A unified photosensitizer platform for <i>in situ</i> DNA-, RNA-, and protein-directed proximity labeling.

bioRxiv : the preprint server for biology·2026
Same author

Semantic Communication Based on Slot Attention for MIMO Transmission in 6G Smart Factories.

Sensors (Basel, Switzerland)·2026
Same author

Preclinical Evaluation of Triptophenolide-Induced Apoptosis in Hepatoblastoma (HepG2) and Hepatocellular Carcinoma (HuH7) Cell Lines.

International journal of molecular sciences·2026

Related Experiment Video

Updated: Jun 26, 2025

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

7.9K

Sensing antibody functions with a novel CCR8-responsive engineered cell.

Jianyu Hao1, Yitong Lv1, Xufeng Xiao2

  • 1College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.

Acta Biochimica Polonica
|May 9, 2024
PubMed
Summary

A new cell line aids in evaluating anti-CCR8 antibody therapies for cancer and autoimmune diseases. This reporter system offers sensitive and specific detection of antibody functions, improving drug development.

Keywords:
CCR8HEK293-cAMP-biosensor-CCR8engineered cell linefunctional evaluationmonoclonal antibody

More Related Videos

Genetically-encoded Molecular Probes to Study G Protein-coupled Receptors
16:16

Genetically-encoded Molecular Probes to Study G Protein-coupled Receptors

Published on: September 13, 2013

15.2K
Author Spotlight: Optimizing Antibody-Based Cancer Treatments via Antibody-Dependent, Cell-Mediated Cytotoxicity Assay
05:21

Author Spotlight: Optimizing Antibody-Based Cancer Treatments via Antibody-Dependent, Cell-Mediated Cytotoxicity Assay

Published on: September 13, 2024

345

Related Experiment Videos

Last Updated: Jun 26, 2025

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

7.9K
Genetically-encoded Molecular Probes to Study G Protein-coupled Receptors
16:16

Genetically-encoded Molecular Probes to Study G Protein-coupled Receptors

Published on: September 13, 2013

15.2K
Author Spotlight: Optimizing Antibody-Based Cancer Treatments via Antibody-Dependent, Cell-Mediated Cytotoxicity Assay
05:21

Author Spotlight: Optimizing Antibody-Based Cancer Treatments via Antibody-Dependent, Cell-Mediated Cytotoxicity Assay

Published on: September 13, 2024

345

Area of Science:

  • Immunology
  • Pharmacology
  • Biotechnology

Background:

  • Human chemokine receptor 8 (CCR8) is a key target for cancer and autoimmune disease immunotherapies.
  • Monoclonal antibodies targeting CCR8 demonstrate significant tumor growth inhibition and improved antitumor immunity.
  • Advancements in antibody evaluation methods are crucial for CCR8-targeted drug development.

Purpose of the Study:

  • To develop a novel engineered cell line for evaluating anti-CCR8 antibody functions.
  • To establish a sensitive and specific platform for assessing antibody specificity, biological activity, and effector functions.
  • To validate the utility of the reporter cell line with a newly developed CCR8 monoclonal antibody.

Main Methods:

  • Construction of a customized HEK293 cell line engineered with CCR8 and a cAMP-biosensor reporter.
  • Utilizing the reporter cell line to detect anti-CCR8 antibody specificity and biological activity.
  • Assessing antibody-dependent cell-mediated cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP) using the reporter system.

Main Results:

  • Successful development of the HEK293-cAMP-biosensor-CCR8 reporter cell line.
  • Verification of biological activities of a new CCR8 monoclonal antibody (mAb 22H9) using the developed cell line.
  • Demonstration of high sensitivity and specificity of the reporter cell line for evaluating anti-CCR8 antibodies.

Conclusions:

  • The novel engineered cell line provides a robust platform for evaluating anti-CCR8 antibody functions.
  • This reporter system facilitates rapid kinetic detection and characterization of antibody efficacy.
  • The developed cell line supports the advancement of CCR8-targeted immunotherapies for cancer and autoimmune diseases.